chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu-like symptoms; muscles, joints and bones all had high levels of pain; muscles, joints and bones all had high levels of pain; muscles, joints and bones all had high levels of pain; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date (at the age of 74-years-old) as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported) via an unspecified route of administration in left arm on 26Jan2021 (at the age of 74-years-old) as dose 2, single for COVID-19 immunization. Medical history included pneumonia (had pneumonia three times as an adult, pneumonia shots 3 to 4 times), Chickenpox (Immunized as a child for chicken pox), Shingles (Two shingles shots), atrial fibrillation, fatty liver, hardening of the arteries, Chronic kidney disease stage 3, Smoker (At least one pack per day for 53 plus years), Mumps (Immunized as a child for mumps), measles (Immunized as a child for measles) and Statins allergy. Concomitant medications included atenolol; rivaroxaban (XARELTO); escitalopram; lamotrigine; omeprazole (LOSAR). The patient previously took Dimetapp and experienced drug allergy, niacin, and experienced drug allergy. Historical vaccine included Flu vaccine for influenza immunization (annual flu shot for at least 25 plus years). Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any vaccines within four weeks. The patient experienced flu-like symptoms and muscles, joints, and bones all had high levels of pain on an unspecified date, within 12 hours receiving the first shot. On 27Jan2021, the patient also experienced same events after receiving second shot. Patient received treatment with tramadol and Tylenol. The treatment alleviated only the intensity a bit, within 12 hours of onset; the pains disappeared, and his body returned to normal levels of pain. The patient had no other symptoms, no headaches, nausea, and tremors. The clinical outcome of flu-like symptoms, joints pain and bones all had high levels of pain were recovered within 12 hours. Outcome of all events was resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
she experienced rapid heartbeat/ her heart rate kept fluctuating from her natural 50-60bpm to 135 and 110 bpm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number and expiry date unknown), via an unspecified route of administration on 27Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient experienced rapid heartbeat and went to the ER as directed by the Fact Sheet for Recipients. She said that she had these tests: EKG, X-ray, and some blood test on an unspecified date with unknown results. She mentioned that her heart rate kept fluctuating from her natural 50-60bpm to 135 and 110 bpm. She wanted to know if she should take the second dose considering this adverse event. The outcome of the event was unknown  Information on the lot/batch number has been requested.
9/7: VACCINATION AT STORE PHARMACY @ 4PM  9/8: LESS THAN 24 HRS AFTER 1ST SHOT: NUMBNESS IN MY RIGHT LEG MOST OF THE DAY FROM MY HIP DOWN. COULD NOT FEEL LEG. FELT OFF BALANCED  9/9: ALMOST 47 HOURS AFTER 1ST SHOT: SAT AT MY DESK FOR MOST OF THE DAY WORKING.  APPROX. 3PM EXTREME PAIN AND COULD NOT WALK. COULD NOT MOVE FROM CHAIR. MOST INTENSE PAIN. PAIN SO SEVERE I WAS DRY HEAVING & CRYING.  I CAN NOT EXPRESS HOW SEVERE THIS PAIN WAS- I HAD A LONG HARD LABOR AND LABOR WAS NOTHING COMPARED TO THIS. IT WAS SCARY.  COULD NOT WALK FOR A FEW ( 3 ) HOURS. SON CALLED HUSBAND AND I WAS TAKEN TO THE MED. GOT SHOT TO HELP WITH THE PAIN AND AN XRAY. PRESCRIBED PAIN PILLS AND TOLD TO REST. PAIN WAS MOST INTENSE AT MY HIP AND RADIATED DOWN MY LEG &  LOWER BACK. IT WAS THE WORST PAIN AND AFRAID I WOULD NOT BE ABLE TO WALK EVER. PHYSICALLY COULD NOT WALK FOR A COUPLE HOURS. ONCE I WAS ABLE TO ATTEMPT WALKING, COULD ONLY DO SO WITH A LIMP AND CANE. LIMPING LASTED THE REST OF THE NIGHT AND NEXT DAY. UP MOST OF THE NIGHT WITH PAIN.   9/10: HAD TO WORK FROM BED. EXTREME DIZZINESS AND SICK TO STOMACH. RIGHT HIP/LEG AND RIGHT SIDE LOWER BACK DULL/ NAGGING PAIN. EVERY TIME I GOT UP, I GOT SICK TO MY STOMACH AND DIZZY.  9/11-9/12: DIZZINESS BOTH DAYS AND EXTREMELY TIRED.    9/11: HIP PAIN BETTER. FOOT ONLY  NUMB.  TRIED TO GET HAIRCUT AND HAD TO HAVE A FAN PUT ON ME UNTIL BETTER AND LEFT SALON TO GO BACK HOME DUE TO DIZZINESS.  9/12: TRIED TO REPORT ONLINE TO CDC AND GOT KICKED OUT 2X.  10/1: DR APPOINTMENT TO REPORT ISSUES AND DISCUSS 2ND SHOT POSSIBLE REACTIONS.
Pt started kindergarten in September, received tdap vaccine on Friday 7/26/19, from PCP office (location and name was not provided). Subsequently started to have expanding redness. Had a temp of 101.3 yesterday. No fever today, arm looks worse, + hot and swollen to touch. + mild itchiness. Cold compress 10 min and 10 min three time/day claritin daily.Demarcate the area. Monitor over the next 5 hrs, If no improvement with above then will start cephalexin due to the extent of erythema cephalexin 250/5 ml , 5 ml po three times/day. ER warning discussed, then to report to urgent care center for in-person eval right away.Advised to contact the doctor and inform of the incident.  F/U with PCP.
Started with discomfort on arm where the vaccine was administered. When I got up to take acetaminophen, I felt very dizzy, nauseous,  stay up, couldn't talk, after I drank cold water, I started with profuse sweating followed by chills, also had lower abdominal pain and pain on the left side of the chest. I went to the bathroom and did not have diarrhea. I was finally able to get up with help from my wife. Slow walking. The event lasted about 15 minutes. Since then I've take acetaminophen every 4 hrs.
Got an expired dose; This spontaneous case was reported by an other and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Got an expired dose) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Got an expired dose). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Got an expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications information was not provided by the reporter. The number of doses/vials were one vial/ three doses. Treatment information was not provided by the reporter. The vial did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 17-Sep-2021: Follow up received contains updated contact details.
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and TREMOR (shakes) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.  The patient's past medical history included COVID-19 (Tested + (positive) for COVID19 on 25thJAN2021.) on 25-Jan-2021.  On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PYREXIA (fever) and TREMOR (shakes). At the time of the report, PYREXIA (fever) and TREMOR (shakes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.   No treatment details was reported.   This case was linked to MOD-2021-031753 (Linked Report).; Sender's Comments:  MOD-2021-031753:Husband case
Patient developed a rash around the injection site. Itchiness, currently taking Benadryl as prescribed. No other symptoms or fever reported.
Feeling dizzy upon dressing for school.  Eyes rolled back and lost consciousness into arms of mother.  Mother held her upright and patient had a few jerks.  She did not regain consciousness for 5 minutes.
After second dose patient reports rash that spread to entire body, shortness of breath, shakiness, fatigue
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided.  In or around 21-DEC-2015, the patient was inoculated with ZOSTAVAX (lot# and route not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Approximately two days after receiving ZOSTAVAX the patient suffered blisters on his back to right side and was diagnosed with shingles. As a direct and proximate result of the ZOSTAVAX vaccine, the patient's symptoms have resulted in physical limitations not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of ZOSTAVAX vaccine, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of ZOSTAVAX vaccine, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of ZOSTAVAX, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. Shingles was reported to be disabling. Additional information has been requested.
Suprasternal chest tightness without wheezing - within 5 min of HAVRIX (Hepatitis A) & POLIO (IePV) vaccine Resolved in 20 min after liquid BENADRYL given Respiratory distress - Allergy. ? may be secondary to 2-phenoxyethanl?
Itching on injection site and rash and itching on elbow.  Pain in site radiating to shoulder, elbow, and lower arm muscles.
itchy all over the body except face; hives; face is slightly red; night sweats; This case was reported by a consumer via call center representative and described the occurrence of pruritus in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th October 2020, the patient received the 1st dose of Shingrix. On 17th October 2020, 5 days after receiving Shingrix, the patient experienced night sweat. On 19th October 2020, the patient experienced pruritus, hives and erythema. On an unknown date, the outcome of the pruritus, hives, night sweat and erythema were unknown.   It was unknown if the reporter considered the pruritus, hives, night sweat and erythema to be related to Shingrix.  Additional details were provided as follows: The case was reported by the husband of the patient. The patient received Shingrix and had night sweats and no fever.  7 days after the patient had pruritus, hives and erythema. At the time of reporting the patient had hives which are itchy all over the body except face. The face was slightly red. The reporter consented to follow up.
Fever up to 104 degrees; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever up to 104 degrees) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2021, the patient experienced PYREXIA (Fever up to 104 degrees). At the time of the report, PYREXIA (Fever up to 104 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-May-2021, Body temperature: 104 (High) fever up to 104 degrees. On an unknown date, Body temperature: 103.8 (High) Fever 103.8.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Information has been received from a physician concerning a 17 year old female on an unknown date was vaccinated with the second dose of GARDASIL.  After getting the second dose, the patient fainted and hit her head (causing a gash on her head).  The patient sought medical attention.  The patient's outcome was not reported.  Patient fainted and hit her head (causing a gash on her head) were considered to be disabling by the reporting physician.  Additional information has been requested.
symptoms started 4-5 hours after the shot was given on Jan, 08 2021, were presented with rash, redness, swelling, pain, itchiness and warm to touch. symptoms are still presenting and not going away with increasing of itchiness, rudeness and swelling especially at night time.   treatment:  acetaminophen, ibuprofen and ice.
Pain; Shingles like lesions; Painful lesions on the ear, scalp, temple; Post herpetic neuralgia; This serious case was reported by a nurse via sales rep and described the occurrence of vesicular rash in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular, unknown deltoid). On an unknown date, 1 day after receiving Shingrix, the patient experienced vesicular rash (Verbatim: Shingles like lesions) (serious criteria hospitalization), painful rash (Verbatim: Painful lesions on the ear, scalp, temple) (serious criteria hospitalization), pain (Verbatim: Pain) (serious criteria hospitalization) and post herpetic neuralgia (Verbatim: Post herpetic neuralgia). The patient was treated with valaciclovir hydrochloride (Valtrex), prednisone, antivirals nos and gabapentin. The outcome of the vesicular rash was unknown and the outcome of the painful rash was not reported and the outcome of the pain and post herpetic neuralgia were not resolved.   It was unknown if the reporter considered the vesicular rash, painful rash, pain and post herpetic neuralgia to be related to Shingrix.     It was unknown if the company considered the vesicular rash, painful rash, pain and post herpetic neuralgia to be related to Shingrix.   Additional Information: GSK receipt date: 19-MAY-2023 The reporter stated that one day after the Shingrix vaccination the patient developed one lesion on her right arm. On an unknown day, the patient developed painful lesions on the ear, scalp, temple and nose in a trigeminal pattern.  The patient was treated with Valtrex and prednisone. Twelve days post vaccination, the patient was admitted to the hospital for 2 days to receive IV antivirals. Two months after receiving vaccination, the patient had post herpetic neuralgia and was being treated with gabapentin. Nothing else was reported. The reporter consented to follow up.
In the morning, I was very tired, but still managed to work. After coming back home at night, I was caught by a low fever (99.7 degree), as well as headache, tired feeling, insomnia, and stomach pain.   All the symptoms except headache were relieved after 2 days; then red rashes appeared around my body.   In the first day, I found 14 rashes with one was itchy. More rashes appeared in the second day, which is now, 07/26/2014.
Caller received her second Covax injection 2 1/2 weeks ago and the injection site still itches; This is a spontaneous report from Pfizer-sponsored program. A contactable consumer, the patient, reported a female of unspecified age received the second dose of BNT162b2 (solution for injection; batch/lot and expiry information reported as not available) as a single dose via unspecified route on an unspecified date in Feb2021, described as two and a half weeks ago, for COVID-19 immunisation. There was no medical history, concomitant medications or past drug history reported. The patient reported that she received the second dose of the vaccine two and a half weeks ago and the injection site still itches. The patient inquired why that is and if the vaccination did not take or something that is causing it to still itch. The outcome of the event injection site still itches was not recovered.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
extra dose administered; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 44-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 97NL3, expiry date 5th June 2021) for prophylaxis.   Concomitant products included DTPa (Reduced antigen) (Boostrix).   On 16th April 2019, the patient received Boostrix (intramuscular). On 16th April 2019, unknown after receiving Boostrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were provided as follows: This case was reported by medical assistant. On 16th April 2019, the patient accidentally received a Boostrix dose when he already had the dose received on 10th April 2019. This case was identified as duplicate of US2019069958. Case US2019069958 was deleted and all the future correspondence will be added in the present case which stands as case of record for this patient.   Follow up information was received from other health professional on 15th May 2019: At the time of reporting, the patient was doing fine with no adverse reaction. The VAERS details were updated.
pt recv vax 10AM & was fine up til 4AM started cranky w/low fever (99-100) crying constantly from 7AM-12PM all day & applied cool wash cloth to leg;diarrhea & vomiting throughout day;
Unusual menstrual cycle. I missed a period and then had a very short heavy period and then missed another period but have had spotting every day.
pt recv vax 26FEB96 & 16MAR96 pt exp gen body ache that progressed to an itchy rash by 19MAR96;it became a vesicular rash by 21MAR96;no further details were provided;
5 min. after FLUMIST. C/O abdominal pain, followed by harsh cough, wheezing. Treatment albuterol neb 2x, PRELONE 15/5ml, 5ml.
bled profusely; exposure via skin contact; underdose; This case was reported by a pharmacist via call center representative and described the occurrence of injection site hemorrhage in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number MT2A4, expiry date 11th September 2021) and (batch number 497D9, expiry date 11th September 2021) for prophylaxis.   The patient's past medical history included motor vehicle accident (several weeks prior to vaccination).   On 13th June 2019, the patient received Shingrix. On an unknown date, the dose was an unknown dose. On 13th June 2019, immediately after receiving Shingrix, the patient experienced injection site hemorrhage, exposure via skin contact and accidental underdose. On an unknown date, the outcome of the injection site hemorrhage, exposure via skin contact and accidental underdose were unknown.   It was unknown if the reporter considered the injection site hemorrhage to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that blood shot from the injection site upon administration of Shingrix, after removing the needle blood and clear fluid leaked from the site, which led to injection site hemorrhage, exposure via skin contact and accidental underdose.  The reporter denied signs of a hematoma at the injection site.  No additional details provided.
Non-Responder to 6 Doses of a Previous Hepatitis B Vaccine Responded to Heplisav Series; Initial Report Received on 08-Nov-2021  In a case series, patients with documentation of 6 doses of a standard hepatitis B vaccine, received 2 doses of Heplisav-B, and the results of post-vaccination tests were collected from existing health records within the specified health system.    Patient received an initial hepatitis B series at 69-years-old and a second hepatitis B series at 71-years-old.   A total of 6 doses of the standard hepatitis B vaccine were administered. The patient was considered a non-responder.  At 72-years-old, the patient received the initial dose of Heplisav-B.   The patient completed the Heplisav-B series (details not specified).   On an unspecified date, at least 1 month after completing the Heplisav-B series, the hepatitis B surface antibody was positive.  No additional information was provided.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
I developed a rash below the injection site that was splotchy red and itchy. It was a little warm to the touch, and at first I thought I had a spider bite but read it could be a reaction to the Moderna vaccine. I used benadryl ointment to calm the symptoms and the rash has essentially disappeared as of today.
low grade fever of 99.3 degrees F; nausea for a couple of hours; daughter has been tired the last two days; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PYREXIA (low grade fever of 99.3 degrees F), FATIGUE (daughter has been tired the last two days) and NAUSEA (nausea for a couple of hours) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient had no medical history other than allergies. The patient is not tested or diagnosed for COVID.  Concurrent medical conditions included Fruit allergy (pineapples), Allergy to molds and Allergy to animal (dog dandruff).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2022, the patient experienced FATIGUE (daughter has been tired the last two days). On an unknown date, the patient experienced PYREXIA (low grade fever of 99.3 degrees F) and NAUSEA (nausea for a couple of hours). In August 2022, FATIGUE (daughter has been tired the last two days) had resolved. At the time of the report, PYREXIA (low grade fever of 99.3 degrees F) had not resolved and NAUSEA (nausea for a couple of hours) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.3 99.3 degrees F.         Patient was not receiving concomitant medication. No treatment drug was reported. The patient still had low grade fever of 99.3 degrees F.
The vaccine administered was expired on 09/30/22.   Per manufacture, the vaccine is still effective until 10/19/22
I developed leg weakness in august, 2021.  In Oct. 2021, I developed a left foot drop. November/December balance issues and continued weakness in legs.  December, 2021  through  March 2022, muscle wasting and significant weight loss. March 2022, Speech getting slurred. Diagnosed with ALS May, 2022.